Dietary salt reduction and exercise are lifestyle modifications for salt‐sensitive hypertensives. While exercise has prominent metabolic effects, salt has an adverse effect on metabolic syndrome, of which hypertension is a hallmark. We hypothesized that dietary salt impacts metabolism in a salt‐sensitive model of hypertension. An untargeted metabolomics approach demonstrates lower circulating levels of the ketone body, beta‐hydroxybutyrate (βOHB), in high salt‐fed hypertensive rats. Despite the high salt intake, specific rescue of βOHB levels by nutritional supplementation of its precursor, 1,3‐butanediol, attenuates hypertension and protects kidney function. This beneficial effect of βOHB was likely independent of gut‐microbiotal and Th17‐mediated effects of salt and instead facilitated by βOHB inhibiting the renal Nlrp3 inflammasome. The juxtaposed effects of dietary salt and exercise on salt‐sensitive hypertension, which decrease and increase βOHB respectively, indicate that nutritional supplementation of a precursor of βOHB provides a similar benefit to salt‐sensitive hypertension as exercise.
Support or Funding Information
Funding from this work to BJ from the NHLBI (NIH) (HL143082) is gratefully acknowledged.
Declaration of interests: Bina Joe and Saroj Chakraborty have an interest in U.S. Patent Application Serial No.: 62/665,690 filed on May 2, 2018 in this paper regarding nutritional intervention for salt‐sensitive hypertension for 1,3‐butanediol.
This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.